Movement Alert｜KEYMED BIO-B falls 5.03% in Regular Trading, stake cut by shareholder after holding drops below 5%

Market Focus11-03

On November 3, KEYMED BIO-B fell 5.03% in Regular Trading, trading at HK$63.3, with turnover of HK$228 million.

The clearest recent catalyst is a shareholder stake reduction: a filing disclosed that China Asset Management Fund sold 991,000 shares on October 27 at an average price of HK$70.8951, cashing out about HK$70.26 million, with its long position ratio falling from 5.08% to 4.75%.

Separately, the company’s October monthly return published on November 2 showed no new share issuance, repurchase, cancellation, or treasury share movement, indicating an unchanged share capital structure. That update was largely neutral, while the earlier reduction below the 5% threshold appears to carry the more direct trading signal for recent pressure on the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment